Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2025 Filed Feb 24, 2025 17:47 UTC |
NEWHALL CHARLES W IIIDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007476 · wk-form4_1740437240.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,369 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 17:47 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantCommon Stock | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007476 · wk-form4_1740437240.xml · nonDerivative · entry 1 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,644 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:20 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007532 · wk-form4_1740446408.xml · derivative · entry 8 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F6 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F6 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:20 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007532 · wk-form4_1740446408.xml · derivative · entry 7 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:20 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007532 · wk-form4_1740446408.xml · nonDerivative · entry 4 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,853 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:20 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007532 · wk-form4_1740446408.xml · nonDerivative · entry 3 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,603 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:18 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007528 · wk-form4_1740446308.xml · derivative · entry 8 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F6 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F6 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:18 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007528 · wk-form4_1740446308.xml · derivative · entry 7 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:18 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007528 · wk-form4_1740446308.xml · nonDerivative · entry 4 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,024 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:18 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007528 · wk-form4_1740446308.xml · nonDerivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,774 Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 17:50 UTC |
Hudson Frederick M.Director
|
Disposition to issuerRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007479 · wk-form4_1740437446.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,369 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 17:50 UTC |
Hudson Frederick M.Director
|
GrantCommon Stock | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007479 · wk-form4_1740437446.xml · nonDerivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,764 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:16 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Unit · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007526 · wk-form4_1740446208.xml · derivative · entry 5 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:16 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Unit · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007526 · wk-form4_1740446208.xml · derivative · entry 4 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F2 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:16 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007526 · wk-form4_1740446208.xml · nonDerivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,591 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:16 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007526 · wk-form4_1740446208.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,591 Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 22:45 UTC |
GEMAYEL GEORGESDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007463 · wk-form4_1740437106.xml · derivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,369 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 22:45 UTC |
GEMAYEL GEORGESDirector
|
GrantCommon Stock | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007463 · wk-form4_1740437106.xml · nonDerivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,684 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:22 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007534 · wk-form4_1740446545.xml · derivative · entry 8 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F6 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F6 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:22 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007534 · wk-form4_1740446545.xml · derivative · entry 7 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:22 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007534 · wk-form4_1740446545.xml · nonDerivative · entry 4 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,939 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 01:22 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007534 · wk-form4_1740446545.xml · nonDerivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,689 Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 22:43 UTC |
Barlow CarroleeDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007461 · wk-form4_1740436987.xml · derivative · entry 2 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,369 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 22:43 UTC |
Barlow CarroleeDirector
|
GrantCommon Stock | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007461 · wk-form4_1740436987.xml · nonDerivative · entry 1 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,570 Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 22:41 UTC |
Sensenig BethanyDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007459 · wk-form4_1740436862.xml · derivative · entry 2 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,369 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 22:41 UTC |
Sensenig BethanyDirector
|
GrantCommon Stock | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007459 · wk-form4_1740436862.xml · nonDerivative · entry 1 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:20 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Exercise / conversionPerformance Share Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007532 · wk-form4_1740446408.xml · derivative · entry 6 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F3 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:20 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
SaleCommon Stock | 927 | $39.15 | $36,292.05 |
DisclosureSEC source: 0001628280-25-007532 · wk-form4_1740446408.xml · nonDerivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,853 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:20 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007532 · wk-form4_1740446408.xml · nonDerivative · entry 1 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:18 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Exercise / conversionPerformance Share Units · Derivative | 1,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007528 · wk-form4_1740446308.xml · derivative · entry 6 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F3 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:18 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Tax withholdingCommon Stock | 552 | $39.15 | $21,610.80 |
DisclosureSEC source: 0001628280-25-007528 · wk-form4_1740446308.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,024 F2 · price: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:18 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Exercise / conversionCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007528 · wk-form4_1740446308.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 21, 2025. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:22 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionPerformance Share Units · Derivative | 1,650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007534 · wk-form4_1740446545.xml · derivative · entry 6 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period. F3 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:22 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Tax withholdingCommon Stock | 860 | $39.15 | $33,669.00 |
DisclosureSEC source: 0001628280-25-007534 · wk-form4_1740446545.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,939 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 01:22 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionCommon Stock | 1,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007534 · wk-form4_1740446545.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 21:42 UTC |
Khattar Jack A.Director · President, CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 331,660 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001628280-25-007147 · wk-form4_1740174115.xml · derivative · entry 3 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,660 Underlying: Common Stock · 331,660 shares Expires 2035-02-20 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 16:50 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007189 · wk-form4_1740174641.xml · derivative · entry 3 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,475 Underlying: Common Stock · 4,475 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 16:50 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,296 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001628280-25-007189 · wk-form4_1740174641.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,296 Underlying: Common Stock · 7,296 shares Expires 2035-02-19 F1 · derivative.exercise_date: The option vests on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:44 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007165 · wk-form4_1740174269.xml · derivative · entry 3 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:44 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001628280-25-007165 · wk-form4_1740174269.xml · derivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:57 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantRestricted Stock Unit · Derivative | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007194 · wk-form4_1740175057.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:57 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001628280-25-007194 · wk-form4_1740175057.xml · derivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 16:51 UTC |
Hudson Frederick M.Director
|
GrantRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007191 · wk-form4_1740174702.xml · derivative · entry 3 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,475 Underlying: Common Stock · 4,475 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 16:51 UTC |
Hudson Frederick M.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,296 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001628280-25-007191 · wk-form4_1740174702.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,296 Underlying: Common Stock · 7,296 shares Expires 2035-02-19 F1 · derivative.exercise_date: The option vests on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:43 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantRestricted Stock Unit · Derivative | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007156 · wk-form4_1740174196.xml · derivative · entry 3 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:43 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001628280-25-007156 · wk-form4_1740174196.xml · derivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2035-02-19 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:49 UTC |
GEMAYEL GEORGESDirector
|
GrantRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007186 · wk-form4_1740174572.xml · derivative · entry 3 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,475 Underlying: Common Stock · 4,475 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:49 UTC |
GEMAYEL GEORGESDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,296 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001628280-25-007186 · wk-form4_1740174572.xml · derivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,296 Underlying: Common Stock · 7,296 shares Expires 2035-02-19 F1 · derivative.exercise_date: The option vests on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:48 UTC |
Sensenig BethanyDirector
|
GrantRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007182 · wk-form4_1740174492.xml · derivative · entry 2 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,475 Underlying: Common Stock · 4,475 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:48 UTC |
Sensenig BethanyDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,296 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001628280-25-007182 · wk-form4_1740174492.xml · derivative · entry 1 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,296 Underlying: Common Stock · 7,296 shares Expires 2035-02-19 F1 · derivative.exercise_date: The option vests on February 19, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.